ctrl K

Watchlist Price Alert

NewAmsterdam Pharma N.V. (NAMS)

NASDAQ: NAMS · Real-Time Price · USD

18.78

0.08 (0.43%)

At close: May 16, 2025, 10:14 AM

NewAmsterdam Pharma Revenue Breakdown

Period Ending	Dec 31, 2022
License Revenue Revenue	93.5M
License Revenue Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Selling, General, and Administrative Revenue	27.15M	24.31M	17.28M	15.38M	13.39M	10.17M	10.92M	9.03M	7.43M	4.79M	5.3M	4.65M	4.65M	2.17M	1.7M	700.5K	700.5K	104.33K	348.5K	348.5K	348.5K
Selling, General, and Administrative Revenue Growth	+11.69%	+40.71%	+12.34%	+14.83%	+31.73%	-6.91%	+20.91%	+21.55%	+55.26%	-9.73%	+14.12%	0.00%	+113.68%	+27.85%	+142.83%	0.00%	+571.40%	-70.06%	0.00%	0.00%	n/a
Research and Development Revenue	44.75M	34.9M	35.7M	35.83M	39.32M	35.72M	38.92M	31.47M	37.26M	27.03M	28.96M	15.29M	15.29M	8.68M	8.24M	4.28M	4.28M	1.01M	1.01M	1.01M	1.01M
Research and Development Revenue Growth	+28.24%	-2.26%	-0.35%	-8.88%	+10.07%	-8.22%	+23.68%	-15.55%	+37.87%	-6.66%	+89.33%	0.00%	+76.25%	+5.31%	+92.67%	0.00%	+322.89%	0.00%	0.00%	0.00%	n/a